In melanoma, the abundance of cytoplasmic and nuclear β-catenin results from the downregulation of E-cadherin, promoting tumorigenic signaling, whereas in normal SSCs, E-cadherin sequesters β-catenin [157]. The gene discussed is CDH1; the disease is melanoma.